lobbying_activities: 2959315

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2959315	b6304ba1-315a-46b5-a9e8-c18651cbbb2d	Q1	MS. TAMI WAHL	401104405	TRADITIONAL MEDICINALS	2023	first_quarter	FOO	To clarify the regulatory uncertainty of the hemp-derived cannabidiol ingredient; to explore the implications from mandatory dietary supplement product listing provisions (as previoulsy included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348)); to explore the role and needs of small businesses for market entry.	HOUSE OF REPRESENTATIVES,SENATE,Small Business Administration (SBA)	10000		0	0	2023-04-14T11:21:27-04:00